Filter
368
Text search:
Trachoma
Featured
48
90
Language
Document type
155
81
33
31
27
14
8
6
4
3
3
2
1
Countries / Regions
26
13
9
7
6
6
6
6
5
5
5
5
5
4
4
3
3
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
108
42
28
23
6
6
Toolboxes
129
22
18
11
8
7
6
5
5
4
3
3
3
2
2
1
1
1
1
1
Weekly Epidemiological Record. This report summarizes application of the SAFE strategy against trachoma during 2023. It includes estimates of the global population at risk of trachoma blindness base
...
Cureus 2024 Jan 16;16(1):e52358. doi: 10.7759/cureus.52358
Lancet Glob Health 2022; 10: e491–500
COMMUNITY EYE HEALTH JOURNAL | VOLUME 36 | NUMBER 118 | 2023
COMMUNITY EYE HEALTH JOURNAL | VOLUME 33 | NUMBER 110 | 2020
Twenty-Fourth Annual Trachoma Control Program Review, Summary Proceedings
Surveys are needed to guide trachoma control efforts in Mozambique, with WHO guidelines for intervention based on the prevalence of trachomatous inflammation–follicular (TF) in children aged 1–9 years and the prevalence of trichiasis in adults a
...
This manual provides a framework for morbidity management and disability prevention of patients affected by NIDs and gives specific guidance for the proper care of patients suffering from chronic conditions caused by lymphatic filariasis, leprosy, trachoma
...
In order to target resources and drugs to reach trachoma elimination targets by the year 2020, data on the burden of disease are required. Using prevalence data in African countries derived from the Global Atlas of
...
Trachoma Atlas is dedicated to eliminating the world's leading infectious cause of preventable blindness
Since 1996, trachoma has been targeted for elimination as a public health problem worldwide. The active trachoma criterion for national elimination as a public health problem is a TF1–9 < 5%, sustained for at least two years in the absence of antibiotic mass drug administration (MDA), in each formerly endemic EU. Using A, F and E, health ministries and their partners have made considerable progress towards achieving this criterion in formerly endemic EUs worldwide. In 2002, an estimated 1517 million people lived in EUs in which EU-wide implementation of the A, F and E components of SAFE were thought to be needed for the purposes of global elimination of
...
Trachoma is the leading infectious cause of blindness (2). It is characterized by repeated
conjunctival infection with particular strains of Chlamydia trachomatis. This scars the conjunctivae and,
in some cases, leads to trichiasis with or without
...
The Fifty-first World Health Assembly,
Recalling resolutions WHA22.29, WHA25.55 and WHA28.54 on the prevention of blindness, and
WHA45.10 on disability prevention and rehabilitation; Aware of previous efforts and progress made in the global fight against infectious eye diseases, in particular
...
Trachoma is one of the 17 WHO-defined Neglected Tropical Diseases
(NTDs) that affect over 1 billion of the world’s poorest and most
marginalized people. It is caused by the bacterium chlamydia trachomatis.
Trachoma is an eye infection affecting both eyes. It is the world’s leading cause of infectious blindness. A bacterium called Chlamydia trachomatis causes trachoma. According to the World Health O
...
Trachoma causes more vision loss and blindness than any other infection in the world. This disease is caused by Chlamydia trachomatis bacteria. Other variants or strains of these bacteria can cause a sexually transmitted infection (chlamydia) and di
...
Trachoma is one of oldest infectious diseases known to humans. It is caused by the bacteria Chlamydia trachomatis, which is transmitted through contact with eye secretions of infected people (shared use of towels and handkerchiefs, contact with fing
...
